IMCR (Immunocore Holdings) Total Assets: $1,072.1 Mil (As of Mar. 2026)


IMCR Immunocore Holdings PLC IMCR
76 GF Score
Price $31.94
GF Value $46.16
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Immunocore Holdings Total Assets?

Immunocore Holdings IMCR -1.72% 76 Total Assets is $1,072.1 Mil as of Mar. 2026. GuruFocus rates IMCR with a GF Score™ of 76/100 and a GF Value™ of $46.16 (Possible Value Trap). The stock has 3 warning signs investors should review.

Immunocore Holdings's Total Assets for the quarter that ended in Mar. 2026 was $1,072.1 Mil.

During the past 12 months, Immunocore Holdings's average Total Assets Growth Rate was 19.00% per year. During the past 3 years, the average Total Assets Growth Rate was 17.80% per year. During the past 5 years, the average Total Assets Growth Rate was 20.50% per year.

During the past 8 years, Immunocore Holdings's highest 3-Year average Total Assets Growth Rate was 29.90%. The lowest was -5.30%. And the median was 17.80%.

Total Assets is connected with ROA %. Immunocore Holdings's annualized ROA % for the quarter that ended in Mar. 2026 was 4.85%. Total Assets is also linked to Revenue through Asset Turnover. Immunocore Holdings's Asset Turnover for the quarter that ended in Mar. 2026 was 0.10.

Immunocore Holdings  (NAS:IMCR) Total Assets Explanation

Total Assets is connected with ROA %.

Immunocore Holdings's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=51.884/( (1067.269+1072.095)/ 2 )
=51.884/1069.682
=4.85 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Immunocore Holdings's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=106.677/( (1067.269+1072.095)/ 2 )
=106.677/1069.682
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Immunocore Holdings Total Assets Related Terms

Immunocore Holdings Total Assets Historical Data

* Premium members only.

The historical data trend for Immunocore Holdings's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immunocore Holdings Total Assets Chart

Immunocore Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial 407.28 526.76 597.00 1,009.51 1,067.27

Immunocore Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,028.01 1,082.39 1,102.50 1,067.27 1,072.10
IMCR
76GF Score
Immunocore Holdings PLC IMCR
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Immunocore Holdings Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Immunocore Holdings's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=381.033+686.236
=1,067.3

Immunocore Holdings's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=393.673+678.422
=1,072.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $1,072.1 Mil mean?
Immunocore Holdings (IMCR) has a Total Assets of $1,072.1 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Immunocore Holdings and its competitors.
Is Immunocore Holdings' Total Assets too high?
Immunocore Holdings' current Total Assets is $1,072.1 Mil. Overall, Immunocore Holdings has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Immunocore Holdings' Total Assets compare to MAZE and DMRA?
Immunocore Holdings' Total Assets of $1,072.1 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Immunocore Holdings and its competitors. Immunocore Holdings's current Total Assets is $1,072.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Immunocore Holdings stock overvalued right now?
Based on GuruFocus' analysis, Immunocore Holdings (IMCR) is currently considered Possible Value Trap. The stock's GF Value™ is $46.16, compared to a current price of $31.94 — trading 30.8% below its estimated fair value. The current Total Assets is $1,072.1 Mil. Immunocore Holdings' overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Immunocore Holdings (IMCR), the current Total Assets is $1,072.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Immunocore Holdings (IMCR) Overvalued in 2026?

Based on GuruFocus' analysis, Immunocore Holdings stock appears to be undervalued. The current stock price of $31.94 is trading 30.8% below its estimated GF Value™ of $46.16. GuruFocus considers Immunocore Holdings to be Possible Value Trap.

Key valuation signals for IMCR:

  • Total Assets: $1,072.1 Mil
  • GF Value™: $46.16 vs. price of $31.94 (30.8% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the IMCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Immunocore Holdings Business Description

Other Exchanges 6YG:Germany
Address 92 Park Drive, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4RY
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
76GF Score

Get the complete analysis for IMCR

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$31.94
Price
$46.16
GF Value